Lynx1 Capital Management LP
SEC insider (Form 3/4/5 filer). CIK 0001910456. 10% Owner at Korro Bio, Inc. (KRRO) and 4 other issuers. 36 reported Form 4/5 transactions since Sep 2024; latest on Oct 26, 2026. Located in DORADO, PR.
Companies Lynx1 Capital Management LP has filed insider reports for
- Korro Bio, Inc. (KRRO): 10% Owner
- Passage BIO, Inc. (PASG): 10% Owner
- TScan Therapeutics, Inc. (TCRX): 10% Owner
- Cullinan Therapeutics, Inc. (CGEM): 10% Owner
- Neuphoria Therapeutics Inc. (NEUP): 10% Owner
Lynx1 Capital Management LP
CIK: 0001910456
Transaction Breakdown
Open Market Buys (P)36 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Oct 26, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect25.1K shares at avg. $11.75$295K - Oct 23, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect2.5K shares at avg. $12.11$30K - Oct 22, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect12.2K shares at avg. $9.68$118K - Oct 22, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect40K shares at avg. $11.04$441K - Aug 10, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect1.5K shares at avg. $13.19$19K - Aug 6, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect5.2K shares at avg. $11.40$60K - Jun 25, 2026PASG
Passage BIO, Inc.
PurchaseIndirect50.1K shares at avg. $4.12$206K - Mar 31, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect520 shares at avg. $10.60$6K - Dec 23, 2025TCRX
TScan Therapeutics, Inc.
PurchaseIndirect6.2K shares at avg. $0.90$6K - Dec 22, 2025TCRX
TScan Therapeutics, Inc.
PurchaseIndirect75.5K shares at avg. $0.90$68K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 26, 2026 |  KRRO Korro Bio, Inc. | Purchase | 25,124 | $11.75 | $295,091 | Indirect |
| Oct 23, 2026 | KRRO Korro Bio, Inc. | Purchase | 2,510 | $12.11 | $30,386 | Indirect |
| Oct 22, 2026 | KRRO Korro Bio, Inc. | Purchase | 12,175 | $9.68 | $117,810 | Indirect |
| Oct 22, 2026 | KRRO Korro Bio, Inc. | Purchase | 40,000 | $11.04 | $441,464 | Indirect |
| Aug 10, 2026 | KRRO Korro Bio, Inc. | Purchase | 1,462 | $13.19 | $19,279 | Indirect |
| Aug 6, 2026 | KRRO Korro Bio, Inc. | Purchase | 5,222 | $11.40 | $59,530 | Indirect |
| Jun 25, 2026 |  PASG Passage BIO, Inc. | Purchase | 50,055 | $4.12 | $206,101 | Indirect |
| Mar 31, 2026 | KRRO Korro Bio, Inc. | Purchase | 520 | $10.60 | $5,512 | Indirect |
| Dec 23, 2025 |  TCRX TScan Therapeutics, Inc. | Purchase | 6,232 | $0.90 | $5,602 | Indirect |
| Dec 22, 2025 | TCRX TScan Therapeutics, Inc. | Purchase | 75,500 | $0.90 | $67,950 | Indirect |
1-10 of 36 transactions